US5545130A
(en)
*
|
1992-04-08 |
1996-08-13 |
Genetronics, Inc. |
Flow through electroporation method
|
US6773669B1
(en)
*
|
1995-03-10 |
2004-08-10 |
Maxcyte, Inc. |
Flow electroporation chamber and method
|
US6103084A
(en)
*
|
1995-06-06 |
2000-08-15 |
Eppendorf Netheler-Hinz Gmbh |
Apparatus for electroporation
|
US6041252A
(en)
*
|
1995-06-07 |
2000-03-21 |
Ichor Medical Systems Inc. |
Drug delivery system and method
|
US5879317A
(en)
*
|
1996-04-30 |
1999-03-09 |
Medtronic, Inc. |
Electrostatic blood defoamer for heart-lung machines
|
US5869326A
(en)
*
|
1996-09-09 |
1999-02-09 |
Genetronics, Inc. |
Electroporation employing user-configured pulsing scheme
|
US6090617A
(en)
*
|
1996-12-05 |
2000-07-18 |
Entremed, Inc. |
Flow electroporation chamber with electrodes having a crystalline metal nitride coating
|
US5903211A
(en)
*
|
1997-02-07 |
1999-05-11 |
Althin Medical, Inc. |
Medical treatment device with a user interface adapted for home or limited care environments
|
US5873849A
(en)
*
|
1997-04-24 |
1999-02-23 |
Ichor Medical Systems, Inc. |
Electrodes and electrode arrays for generating electroporation inducing electrical fields
|
US6055453A
(en)
*
|
1997-08-01 |
2000-04-25 |
Genetronics, Inc. |
Apparatus for addressing needle array electrodes for electroporation therapy
|
AU2868099A
(en)
|
1998-02-13 |
1999-08-30 |
Selective Genetics, Inc. |
Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
|
AU746005B2
(en)
|
1998-05-04 |
2002-04-11 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Electrical integrated nucleic acid isolation, purification and detection
|
US6027488A
(en)
*
|
1998-06-03 |
2000-02-22 |
Genetronics, Inc. |
Flow-through electroporation system for ex vivo gene therapy
|
US20040229363A1
(en)
*
|
1998-06-24 |
2004-11-18 |
Ed Nolan |
High efficiency transfection based on low electric field strength, long pulse length
|
US6150148A
(en)
*
|
1998-10-21 |
2000-11-21 |
Genetronics, Inc. |
Electroporation apparatus for control of temperature during the process
|
AU3804100A
(en)
|
1999-02-15 |
2000-09-04 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Method and sample support system for separating and processing substances in situ
|
US6326177B1
(en)
|
1999-08-04 |
2001-12-04 |
Eastern Virginia Medical School Of The Medical College Of Hampton Roads |
Method and apparatus for intracellular electro-manipulation
|
US6586257B1
(en)
|
1999-10-12 |
2003-07-01 |
Vertex Pharmaceuticals Incorporated |
Multiwell scanner and scanning method
|
US6448089B1
(en)
|
1999-10-12 |
2002-09-10 |
Aurora Biosciences Corporation |
Multiwell scanner and scanning method
|
US6814933B2
(en)
*
|
2000-09-19 |
2004-11-09 |
Aurora Biosciences Corporation |
Multiwell scanner and scanning method
|
WO2001048180A2
(en)
*
|
1999-12-22 |
2001-07-05 |
Innovation And Development Corporation |
Method and apparatus for targeting localised electroporation
|
BR0108959A
(pt)
*
|
2000-03-03 |
2003-10-14 |
Valentis Inc |
Composições de poloxmero ou poloxamina melhoradas para distribuição de ácido nucléico
|
JP2004532654A
(ja)
|
2000-05-22 |
2004-10-28 |
マーク・アンド・カンパニー・インコーポレイテッド |
薬剤投与システム性能評価システム及び方法
|
US7615356B2
(en)
*
|
2000-07-10 |
2009-11-10 |
Vertex Pharmaceuticals (San Diego) Llc |
Ion channel assay methods
|
US7312043B2
(en)
*
|
2000-07-10 |
2007-12-25 |
Vertex Pharmaceuticals (San Diego) Llc |
Ion channel assay methods
|
US20040009940A1
(en)
*
|
2000-10-20 |
2004-01-15 |
Coleman Michael E. |
Gene delivery formulations and methods for treatment of ischemic conditions
|
US7029916B2
(en)
*
|
2001-02-21 |
2006-04-18 |
Maxcyte, Inc. |
Apparatus and method for flow electroporation of biological samples
|
US20040204669A1
(en)
*
|
2001-07-05 |
2004-10-14 |
Hofmann Gunter A. |
Apparatus for electroporation mediated delivery for drugs and genes
|
DK2574662T3
(da)
|
2001-08-22 |
2021-09-20 |
Maxcyte Inc |
Fremgangsmåde til elektroporation af biologiske prøver
|
WO2003026599A1
(en)
*
|
2001-09-26 |
2003-04-03 |
The Procter & Gamble Company |
Personal cleansing compositions comprising silicone resin-containing adhesives
|
AU2002348417B9
(en)
|
2001-10-26 |
2010-02-04 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
US20030170898A1
(en)
*
|
2001-12-04 |
2003-09-11 |
Gundersen Martin A. |
Method for intracellular modifications within living cells using pulsed electric fields
|
DE10208188B4
(de)
*
|
2002-02-20 |
2006-05-24 |
Amaxa Gmbh |
Behälter mit zumindest einer Elektrode
|
US7245963B2
(en)
*
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
CA2477872A1
(en)
|
2002-03-07 |
2003-09-18 |
Merck & Co., Inc. |
Clinical syringe with electrical stimulation aspects
|
US8209006B2
(en)
*
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
AU2003225791A1
(en)
*
|
2002-03-15 |
2003-09-29 |
Department Of Veterans Affairs, Rehabilitation R And D Service |
Methods and compositions for directing cells to target organs
|
US20050233993A1
(en)
*
|
2002-06-05 |
2005-10-20 |
Kadonaga James T |
Methods for promoting homologous recombination
|
US20040115784A1
(en)
*
|
2002-09-30 |
2004-06-17 |
Maxcyte, Inc. |
Apparatus and method for streaming electroporation
|
MXPA05005786A
(es)
*
|
2002-12-03 |
2006-03-08 |
Genetronics Inc |
Placas de electroporacion a gran escala, sistemas y metodos de uso.
|
US6969604B1
(en)
|
2003-06-20 |
2005-11-29 |
Yakovenko Sergey A |
Electroporation chamber
|
EP1660530A2
(de)
|
2003-08-04 |
2006-05-31 |
Advisys, Inc. |
Für canine spezifisches wachstumshormon freisetzendes hormon
|
US7521224B2
(en)
*
|
2003-09-30 |
2009-04-21 |
The United States Of America As Represented By The Secretary Of The Navy |
Microelectronic cell electroporation array
|
WO2005065722A2
(en)
|
2003-12-31 |
2005-07-21 |
Advisys, Inc. |
Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
|
WO2005073371A2
(en)
|
2004-01-20 |
2005-08-11 |
Advisys, Inc. |
Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide
|
US20050282265A1
(en)
*
|
2004-04-19 |
2005-12-22 |
Laura Vozza-Brown |
Electroporation apparatus and methods
|
CA2565316C
(en)
*
|
2004-05-12 |
2017-05-30 |
Maxcyte, Inc. |
Methods and devices related to a regulated flow electroporation chamber
|
US20060165668A1
(en)
*
|
2004-12-10 |
2006-07-27 |
Liu Linda N |
Genetically modified tumor cells as cancer vaccines
|
DE102005029414B4
(de)
*
|
2005-06-24 |
2009-09-03 |
Forschungszentrum Karlsruhe Gmbh |
Verfahren zur Bestimmung des durch Elektroporation bewirkenden Aufschlussgrades biologischer Zellen
|
JP5826450B2
(ja)
*
|
2005-07-22 |
2015-12-02 |
ザ ファウンドリー, エルエルシー |
治療薬の送達のためのシステムおよび方法
|
WO2008006019A2
(en)
|
2006-07-06 |
2008-01-10 |
Advisys Inc. |
Growth hormone releasing hormone treatment to decrease cholesterol levels
|
PT2066399T
(pt)
|
2006-10-17 |
2019-01-11 |
Inovio Pharmaceuticals Inc |
Dispositivos de eletroporação e métodos de usar os mesmos para eletroporação de células em mamíferos
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2011142813A1
(en)
*
|
2010-05-12 |
2011-11-17 |
Cellectis Sa |
Dynamic mixing and electroporation chamber and system
|
WO2012041867A2
(en)
|
2010-09-27 |
2012-04-05 |
China Agricultural University |
Combined antigen and dna vaccine for preventing and treating autoimmune diseases
|
CN103239734B
(zh)
|
2012-02-10 |
2016-02-24 |
北京艾棣维欣生物技术有限公司 |
用于预防和/或治疗呼吸道合胞病毒感染的疫苗
|
KR20230038607A
(ko)
|
2012-12-13 |
2023-03-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Wt1 백신
|
US9592303B2
(en)
|
2013-05-30 |
2017-03-14 |
Duke University |
Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates
|
US10364451B2
(en)
|
2013-05-30 |
2019-07-30 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
US10392611B2
(en)
|
2013-05-30 |
2019-08-27 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
KR20230093536A
(ko)
|
2013-10-07 |
2023-06-27 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
어쥬번트로서 인터류킨-33을 갖는 백신
|
US10370664B2
(en)
|
2013-11-07 |
2019-08-06 |
University Of Southern California |
Use of IKK epsilon inhibitors to activate NFAT and T cell response
|
KR20220061285A
(ko)
|
2013-11-14 |
2022-05-12 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
HIV-1 EnV DNA 백신과 단백질 부스터
|
AU2014354797C1
(en)
|
2013-11-29 |
2018-02-01 |
Inovio Pharmaceuticals, Inc. |
MERS-CoV vaccine
|
EP3092004A4
(de)
|
2014-01-06 |
2017-02-22 |
The Trustees Of The University Of Pennsylvania |
Pd1- und pdl1-antikörper und impfstoffkombinationen und verwendung davon zur immuntherapie
|
KR20230145241A
(ko)
|
2014-10-01 |
2023-10-17 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
항원 및 어쥬번트로서 인터류킨-21을 갖는 백신
|
EP3247808B1
(de)
|
2015-01-21 |
2021-05-05 |
Fred Hutchinson Cancer Research Center |
Poc- und/oder tragbare plattform für gentherapie
|
US11116838B2
(en)
|
2015-01-29 |
2021-09-14 |
The Trustees Of The University Of Pennsylvania |
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
|
US10385115B2
(en)
|
2015-03-26 |
2019-08-20 |
Duke University |
Fibronectin type III domain-based fusion proteins
|
JP6882782B2
(ja)
|
2015-08-04 |
2021-06-02 |
デューク ユニバーシティ |
遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
CN109152818B
(zh)
|
2015-12-21 |
2023-06-23 |
杜克大学 |
具有降低的抗原性的聚合物结合物及其使用方法
|
WO2017173398A1
(en)
|
2016-04-01 |
2017-10-05 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
US20190284263A1
(en)
|
2016-04-29 |
2019-09-19 |
Inovio Pharmaceuticals, Inc. |
In vivo use of chondroitinase and/or hyaluronidase to enhance delivery of an agent
|
US11467156B2
(en)
|
2016-06-01 |
2022-10-11 |
Duke University |
Nonfouling biosensors
|
US10233419B2
(en)
|
2016-06-30 |
2019-03-19 |
Zymergen Inc. |
Apparatuses and methods for electroporation
|
CN109890833A
(zh)
|
2016-09-14 |
2019-06-14 |
杜克大学 |
用于递送亲水性药物的基于三嵌段多肽的纳米粒子
|
CN110023326A
(zh)
|
2016-09-23 |
2019-07-16 |
杜克大学 |
具有lcst行为的非结构化无重复多肽
|
US10376495B2
(en)
|
2016-11-23 |
2019-08-13 |
University Of South Florida |
Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)
|
WO2018132732A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
US10813935B2
(en)
|
2017-02-23 |
2020-10-27 |
Transgenex Nanobiotech, Inc. |
Methods and compositions for treating drug resistance in cancer
|
US11318155B2
(en)
|
2017-02-24 |
2022-05-03 |
University Of South Florida |
Hsp90 activator Aha1 drives production of pathological tau aggregates
|
US10272052B2
(en)
|
2017-02-24 |
2019-04-30 |
University Of South Florida |
Compositions and methods for the treatment of tauopathies
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
EP3829622A4
(de)
|
2018-08-02 |
2022-05-11 |
Duke University |
Doppel-agonisten-fusionsproteine
|
KR102232757B1
(ko)
*
|
2018-11-22 |
2021-03-26 |
(주)엑솔런스바이오테크놀로지 |
체외충격파를 이용한 표적물질 전달 장치
|
CN114340777A
(zh)
*
|
2019-07-02 |
2022-04-12 |
凯拓盘公司 |
用于机电递送的装置、系统和套件及其使用方法
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
DE202020106067U1
(de)
*
|
2019-10-25 |
2020-12-04 |
Life Technologies Corporation |
Systeme und Vorrichtungen zur Elektroporation von zellhaltigen Fluiden
|
BR112022016507A2
(pt)
|
2020-02-25 |
2022-11-22 |
Inovio Pharmaceuticals Inc |
Vacinas contra o coronavírus e métodos de uso
|
US11744885B2
(en)
|
2020-05-14 |
2023-09-05 |
Inovio Pharmaceuticals, Inc. |
Vaccines for recurrent respiratory papillomatosis and methods of using the same
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
AU2021289600A1
(en)
|
2020-06-12 |
2023-01-19 |
University Of Rochester |
Encoding and expression of ACE-tRNAs
|
US12006507B2
(en)
|
2020-07-22 |
2024-06-11 |
Nantcell, Inc. |
Electroporation with active compensation
|
USD965170S1
(en)
|
2020-10-23 |
2022-09-27 |
Life Technologies Corporation |
Electroporation device
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
WO2023057567A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
TW202332694A
(zh)
|
2021-10-07 |
2023-08-16 |
英商阿凡克塔生命科學公司 |
血清半衰期延長之pd-l1結合多肽
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
WO2024102187A1
(en)
|
2022-11-07 |
2024-05-16 |
Pinetree Therapeutics, Inc. |
Combination therapy comprising bispecific antibodies comprising an nrp1 binding domain
|
WO2024129459A1
(en)
|
2022-12-16 |
2024-06-20 |
University Of Rochester |
Repairmen! of barrier dysfunction in esophagus
|